![Eva Engelhardt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 108 118 $ al 31/05/2026
Eva Anette Engelhardt currently works at Bio-Rad Laboratories, Inc., as President-Clinical Diagnostics Group & EVP from 2024.
Ms. Engelhardt also formerly worked at CEPHEID, as Senior VP-Strategy & Marketing.
Ms. Engelhardt received her undergraduate degree and graduate degree from Royal Institute of Technology.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 11/05/2026 | 346 ( 0 % ) | 108 118 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| BIO-RAD LABORATORIES, INC. | Corporate Officer/Principal | 10/06/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
| CEPHEID | Ventas & Marketing | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Bio-Rad Laboratories, Inc.
 Bio-Rad Laboratories, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes life science research products & clinical diagnostics | Health Technology |
CEPHEID
 CEPHEID Medical SpecialtiesHealth Technology Develops, manufactures and markets molecular diagnostic systems | Health Technology |
Royal Institute of Technology
 Royal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
